Product Information
GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $0.2019 per ML under NDC 51672531609. Its NADAC has been published 178 times since May 10, 2023.
FDA first approved this application on Jul 5, 2022. Its Orange Book therapeutic-equivalence code is AA.
Strength
1 mg/5mL
Manufacturer
Taro Pharmaceuticals U.S.A. Inc.NDC
51672531609
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GLYCOPYRROLATEApproval Type
Generic (ANDA)
FDA Application
ANDA212467FDA Approved
7/5/2022
TE Code
AA
On Market Since
7/5/2022
Pharmacological Classes
Price Statistics
The NADAC for GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION has been published 178 times since May 10, 2023, and over the history we have for it it has declined 56.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2019 per ML |
|---|---|
| All-time high | $0.5285 (Jul 12, 2023) |
| All-time low | $0.1689 (May 20, 2026) |
| 52-week high | $0.2559 |
| 52-week low | $0.1689 |
| Median price | $0.3371 |
| Average price | $0.3398 |
| Largest weekly change | +40.9% (Nov 20, 2024) |
| Weeks tracked | 178 |
| Tracking since | May 10, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Glycopyrrolate Oral Solution market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Taro Pharmaceuticals U.S.A. Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Glycopyrrolate Oral Solution market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $0.2019 per ML (NDC 51672531609), effective Sep 30, 2026.
How has the price of GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION changed over time?
Over the history we have for it, the NADAC for GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION has declined 56.6%. It has been tracked across 178 weekly CMS publications since May 10, 2023.
What are the highest and lowest recorded NADAC prices for GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION?
Since May 10, 2023, the NADAC for GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION has ranged from a low of $0.1689 (May 20, 2026) to a high of $0.5285 (Jul 12, 2023), with a median of $0.3371 per ML.
Are there cheaper alternatives to GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION?
GLYCOPYRROLATE 1 MG/5 ML ORAL SOLUTION (NDC 51672531609) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.